Residual disease in HER2-positive early breast cancer : are we escalating the RIGHT patients to T-DM1 or T-DXd?
Source
Translational cancer research - ISSN 2218-676X-15:8 (2026) p.
Vaginal cancer in the second trimester of pregnancy : successful conservative surgery and 21-year disease-free survival
Source
Gynecologic Oncology Reports - ISSN 2352-5789-65 (2026) p.
Beyond recurrence detection : treating the forgotten menopause in endometrial cancer survivors
Source
European journal of obstetrics and gynecology and reproductive biology - ISSN 0301-2115-321 (2026) p. 1-6
Is switching to T-DM1 still justified in HER2-negative residual breast cancer after neoadjuvant systemic therapy?
Source
The Breast - ISSN 0960-9776-81 (2025) p. 1-2
Dynamics of SERPINA3 in response to anthracycline treatment and cardiovascular dysfunction
Source
Cardio-Oncology - ISSN 2057-3804-11:1 (2025) p. 1-13